| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |